Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategy
Biotech
Annexon, Liminal shrink pipelines to focus on possible homeruns
A new year means new culls, and Annexon and Liminal are some of the first biotechs to shrink their clinical ambitions.
Max Bayer
Jan 9, 2023 11:37am
BridgeBio's CEO on staying alive, 'motherhood and apple pie'
May 26, 2022 5:00am
Medtronic builds out executive team with 4 new hires
Nov 15, 2021 10:20am
PDL Biopharma mulls a sale, pledges to dissolve by end of 2020
Mar 12, 2020 10:35am
